Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saima Zafar

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Nature Protocols|October 14, 2016
The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseasesMatthias Schmitz, Maria Cramm, Franc Llorens, et al.
Frontiers in Neurology|March 29, 2017
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive FormsPaula Garcia-Esparcia, Irene López-González, Oriol Grau-Rivera, et al.
Molecular Neurobiology|August 24, 2018
Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt-Jakob Disease and SynucleinopathyMatthias Schmitz, Anna Villar-Piqué, Franc Llorens, et al.
Prion|September 20, 2013
PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2Franc Llorens, Belén Ansoleaga, Paula Garcia-Esparcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2021
Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In VivoTobias Thom, Matthias Schmitz, Anna-Lisa Fischer, et al.
Molecular Neurobiology|March 22, 2017
Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob DiseaseFranc Llorens, Niels Kruse, André Karch, et al.
Acta Neuropathologica|March 19, 2026
A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's diseaseTayyaba Saleem, Wiebke Möbius, Matthias Schmitz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2016
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseasesFranc Llorens, Niels Kruse, Matthias Schmitz, et al.
Plos Pathogens|January 23, 2018
Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesisFranc Llorens, Katrin Thüne, Eulàlia Martí, et al.
Annals of Neurology|February 27, 2019
Seeding variability of different alpha synuclein strains in synucleinopathiesNiccolò Candelise, Matthias Schmitz, Franc Llorens, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Nature Protocols|October 14, 2016
The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseasesMatthias Schmitz, Maria Cramm, Franc Llorens, et al.
Frontiers in Neurology|March 29, 2017
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive FormsPaula Garcia-Esparcia, Irene López-González, Oriol Grau-Rivera, et al.
Molecular Neurobiology|August 24, 2018
Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt-Jakob Disease and SynucleinopathyMatthias Schmitz, Anna Villar-Piqué, Franc Llorens, et al.
Prion|September 20, 2013
PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2Franc Llorens, Belén Ansoleaga, Paula Garcia-Esparcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2021
Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In VivoTobias Thom, Matthias Schmitz, Anna-Lisa Fischer, et al.
Molecular Neurobiology|March 22, 2017
Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob DiseaseFranc Llorens, Niels Kruse, André Karch, et al.
Acta Neuropathologica|March 19, 2026
A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's diseaseTayyaba Saleem, Wiebke Möbius, Matthias Schmitz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2016
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseasesFranc Llorens, Niels Kruse, Matthias Schmitz, et al.
Plos Pathogens|January 23, 2018
Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesisFranc Llorens, Katrin Thüne, Eulàlia Martí, et al.
Annals of Neurology|February 27, 2019
Seeding variability of different alpha synuclein strains in synucleinopathiesNiccolò Candelise, Matthias Schmitz, Franc Llorens, et al.
Pageof 9